<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: How the immune system contains <z:e sem="disease" ids="C0019348" disease_type="Disease or Syndrome" abbrv="">herpes simplex</z:e> virus (HSV) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> is partly understood </plain></SENT>
<SENT sid="1" pm="."><plain>T cells from infected persons proliferate in response to HSV antigens in vitro and may control local relapse rather than <z:e sem="disease" ids="C0948192" disease_type="Disease or Syndrome" abbrv="">primary infection</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>NK cells have been involved in the control of experimental <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>A potentially important, as yet unexplored, population of interest might be the plasmacytoid dendritic cells (PDC), which contrary to monocytes, produce very high amounts of the major antiviral molecules, type-I interferon (IFN) following interaction with HSV </plain></SENT>
<SENT sid="4" pm="."><plain>OBJECTIVES: Measure type-I IFN production, PDC, and NK cells in patients with unusually severe <z:e sem="disease" ids="C1504513" disease_type="Disease or Syndrome" abbrv="">HSV infections</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>STUDY DESIGN: Two female patients of 33- and 50-year-old, respectively were referred because of severe disseminated HSV2 <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> and myelodysplastic marrow </plain></SENT>
<SENT sid="6" pm="."><plain>One patient had <z:mpath ids='MPATH_336'>leukaemia</z:mpath> and a primary HSV2 <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> whereas the other had <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) and a <z:hpo ids='HP_0011010'>chronic</z:hpo> HSV2 <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>The following studies were performed at various time points over 18 months: analysis of the lymphocytes and PDC subsets phenotype, lymphocyte proliferation assays to recall antigens; generation of NK cells in cultures, and production of type-I IFN in serum and by HSV-infected and by sendai virus (SV)-infected blood cells </plain></SENT>
<SENT sid="8" pm="."><plain>RESULTS AND CONCLUSIONS: PDC and NK cells were undetectable in the blood of both patients and NK cells could not be generated in culture at the time of ongoing <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>PBMC failed to produce IFN after <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> with HSV contrasting with a <z:mpath ids='MPATH_458'>normal</z:mpath> T cell proliferation to HSV antigens in patient 1 </plain></SENT>
<SENT sid="10" pm="."><plain>Our observation suggests that innate immunity, through NK cells and PDC may control <z:e sem="disease" ids="C1504513" disease_type="Disease or Syndrome" abbrv="">HSV infections</z:e>, and together with IFN-producing capacity, should be investigated in patients with unusually severe <z:e sem="disease" ids="C1504513" disease_type="Disease or Syndrome" abbrv="">HSV infections</z:e> </plain></SENT>
</text></document>